Related Experiment Video
Updated: Jul 14, 2026

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease
Published on: April 28, 2019
Prospects for a dengue virus vaccine
Stephen S Whitehead1, Joseph E Blaney, Anna P Durbin
1Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA. swhitehead@niaid.nih.gov
Severe dengue is increasing globally, especially in children. Developing a cost-effective tetravalent dengue vaccine effective against all serotypes and providing long-term protection is a critical public health priority.
Area of Science:
- Tropical Medicine
- Vaccinology
- Immunology
Background:
- Severe dengue cases are rising in endemic regions like Southeast Asia and the Americas.
- Children are disproportionately affected by dengue disease.
- An effective dengue vaccine is a global public health priority.
Purpose of the Study:
- To review the immunological challenges in developing a dengue vaccine.
- To discuss the current prospects for an acceptable dengue vaccine.
Main Methods:
- This is a review article, synthesizing existing research on dengue vaccine development.
- Discussion focuses on immunological concerns and vaccine candidate evaluation.
Main Results:
- Developing a tetravalent dengue vaccine effective against all four serotypes presents unique immunological hurdles.
- Existing vaccine candidates face challenges related to efficacy, safety, and duration of protection.
Conclusions:
- Despite challenges, progress in dengue vaccine development is promising.
- An effective, cost-effective, and long-lasting tetravalent dengue vaccine is likely achievable in the near future.
More Related Videos
06:00Portable Paper-Based Immunoassay Combined with Smartphone Application for Colorimetric and Quantitative Detection of Dengue NS1 Antigen
Published on: January 26, 2024
08:36Measuring Dengue Virus RNA in the Culture Supernatant of Infected Cells by Real-time Quantitative Polymerase Chain Reaction
Published on: November 1, 2018
Related Concept Videos
Yellow Fever
Cross-reactivity
Respiratory Syncytial Virus Disease